BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2009
View Archived Issues
Effects of donepezil treatment in AD; data from several studies disclosed at ICAD
Read More
Data from several studies on galantamine reported at ICAD
Read More
Tocotrienol shows potential therapeutic use in diabetic encephalopathy; preclinical data suggest
Read More
Novel S1P1 receptor agonists identified by GlaxoSmithKline
Read More
Nerviano Medical Sciences discovers novel cdc7 and AKT kinase inhibitors
Read More
NeuroSearch patent describes KCNQ channel activators
Read More
Novel ACC inhibitors emerge from AstraZeneca R&D
Read More
QuoNova presents bacterial biofilm formation inhibitors for the treatment of bacterial infections
Read More
Insmed ceases supply of Iplex to new patients and will not initiate further clinical trials
Read More
Novartis signs agreement with Avila for Avilomics covalent drug design platform
Read More
Yakult to initiate trial sites in Japan as part of Celsion's phase III trial of ThermoDox
Read More
CHMP recommends expanded use of MSD's Isentress in adult HIV patients
Read More
CHMP recommends Roche's MabThera in patients with relapsed or refractory CLL
Read More
Eisai submits MAA to Swissmedic for eribulin mesylate for breast cancer
Read More
Movetis receives positive opinion from CHMP for prucalopride in constipation
Read More
Tranzyme receives FDA Fast Track status for TZP-102
Read More
PTC initiates phase II PTC-299 trial in patients with neurofibromatosis type 2
Read More
Novel glucagon and GLP-1 co-agonist reduces obesity pathophysiology in rodents
Read More
ORL1 antagonist MK-1925 shows favorable preclinical activity, selected as clinical candidate
Read More
FDA issues complete response letter for Intuniv extended release for ADHD
Read More
Ariad reports preliminary results from ongoing AP-24534 trial in CML
Read More
Osiris achieves milestone payment for progress in phase II trial of Prochymal
Read More
Raptor and TorreyPines enter into definitive merger agreement
Read More
Quark reports results from study of QPI-1007 in a rat model of glaucoma
Read More
Bristol-Myers commences tender offer to acquire Medarex
Read More
